Which of these two healthcare giants is the better pick for investors?
They're two of the biggies in healthcare. Gilead Sciences
Inc. (NASDAQ:GILD) grew to become the largest biotech in the world over the
last decade on the back of its HIV and hepatitis C franchises. Meanwhile,
Johnson & Johnson (NYSE:JNJ) has remained the biggest healthcare company
overall for years with its consumer products, medical device, and prescription
drug segments.
The companies both cooperate with and compete against each
other. Gilead and J&J teamed up to develop HIV drugs Complera and Eviplera.
In the hepatitis C market, though, Gilead's Sovaldi and Harvoni clobbered
J&J's Olysio.
Which of these two giants is the better pick for investors
right now?...
Source: The Motley Fool